FDA Approves Marketing of Biomove 3000

Curatronic announced that it has obtained FDA marketing approval for the Biomove 3000 Stroke Rehabilitation system. The Biomove 3000 system was specifically developed for home therapy following a stroke. The highly affordable battery-powered device detects extremely small electrical EMG (electromyogram) signals that persist in paralyzed muscles after a stroke and uses these tiny signals to initiate an electrical stimulation impulse to the muscles, resulting in actual muscle movement by the patient.

eMediaWire (http://www.emediawire.com/releases/2005/3/emw217828.htm)